In the present study, we investigated the potential effects of two SNPs (rs1387153 and rs10830963) near/in MTNR1B on the therapeutic efficacy of repaglinide in Chinese patients with T2DM. Here, MTNR1B is linked to type 2 diabetes mellitus.